Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPA for Pain in Knee Osteoarthritis
2020-000249-14Phase 2Completed
- Sponsor
- AKL Research & Development Limited
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing APPA (apocynin + paeonol) with Placebo (2 arms). Primary endpoint: Change from baseline in WOMAC pain sub-score at week 4. Started Jun 2020; status: completed.
02
Drugs
apocyninpaeonol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2020-000249-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000249-14.